Jay D Kranzler - Net Worth and Insider Trading
Jay D Kranzler Net Worth
The estimated net worth of Jay D Kranzler is at least $1,138 dollars as of 2024-11-13. Jay D Kranzler is the Director of Avenue Therapeutics Inc and owns about 559 shares of Avenue Therapeutics Inc (ATXI) stock worth over $1,138. Details can be seen in Jay D Kranzler's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jay D Kranzler has not made any transactions after 2024-11-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jay D Kranzler
Jay D Kranzler Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jay D Kranzler owns 1 companies in total, including Avenue Therapeutics Inc (ATXI) .
Click here to see the complete history of Jay D Kranzler’s form 4 insider trades.
Insider Ownership Summary of Jay D Kranzler
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATXI | Avenue Therapeutics Inc | 2024-09-30 | director |
Jay D Kranzler Latest Holdings Summary
Jay D Kranzler currently owns a total of 1 stock. Jay D Kranzler owns 559 shares of Avenue Therapeutics Inc (ATXI) as of November 5, 2024, with a value of $1,138.
Latest Holdings of Jay D Kranzler
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATXI | Avenue Therapeutics Inc | 2024-11-05 | 559 | 2.04 | 1,138 |
Holding Weightings of Jay D Kranzler
Jay D Kranzler Form 4 Trading Tracker
According to the SEC Form 4 filings, Jay D Kranzler has made a total of 2 transactions in Avenue Therapeutics Inc (ATXI) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Avenue Therapeutics Inc is the sale of 61 shares on November 5, 2024, which brought Jay D Kranzler around $137.
Insider Trading History of Jay D Kranzler
- 1
Jay D Kranzler Trading Performance
GuruFocus tracks the stock performance after each of Jay D Kranzler's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jay D Kranzler is %. GuruFocus also compares Jay D Kranzler's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jay D Kranzler within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jay D Kranzler's insider trading performs compared to the benchmark.
Performance of Jay D Kranzler
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.61 |  | | | | |
| Relative Return to S&P 500(%) | -4.5 | | | | | |
Jay D Kranzler Ownership Network
Ownership Network List of Jay D Kranzler
Ownership Network Relation of Jay D Kranzler
Jay D Kranzler Owned Company Details
What does Avenue Therapeutics Inc do?
Who are the key executives at Avenue Therapeutics Inc?
Jay D Kranzler is the director of Avenue Therapeutics Inc. Other key executives at Avenue Therapeutics Inc include 10 percent owner Fortress Biotech, Inc. , 10 percent owner Invagen Pharmaceuticals, Inc. , and Chief Executive Officer Alexandra Maclean .
Avenue Therapeutics Inc (ATXI) Insider Trades Summary
Over the past 18 months, Jay D Kranzler made 2 insider transaction in Avenue Therapeutics Inc (ATXI) with a net purchase of 439. Other recent insider transactions involving Avenue Therapeutics Inc (ATXI) include a net sale of 617,000 shares made by , a net purchase of 418,410 shares made by Fortress Biotech, Inc. , and a net purchase of 348,675 shares made by Rosenwald Lindsay A Md .
In summary, during the past 3 months, insiders sold 61 shares of Avenue Therapeutics Inc (ATXI) in total and bought 500 shares, with a net purchase of 439 shares. During the past 18 months, 8,288 shares of Avenue Therapeutics Inc (ATXI) were sold and 10,728 shares were bought by its insiders, resulting in a net purchase of 2,440 shares.
Avenue Therapeutics Inc (ATXI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avenue Therapeutics Inc Insider Transactions
Jay D Kranzler Mailing Address
Above is the net worth, insider trading, and ownership report for Jay D Kranzler. You might contact Jay D Kranzler via mailing address: 4350 Executive Drive, Suite 325, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
